The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Serum 25(OH) vitamin D3 response to vitamin D3 supplementation in men with prostate cancer: Results of a randomized phase II trial.
M. H. AL-Hussaini
No relevant relationships to disclose
C. S. Johnson
No relevant relationships to disclose
J. Muindi
No relevant relationships to disclose
M. K. Chadha
No relevant relationships to disclose
C. Silliman
No relevant relationships to disclose
L. Tian
No relevant relationships to disclose
W. Tan
No relevant relationships to disclose
M. Nesline
No relevant relationships to disclose
A. Sandecki
No relevant relationships to disclose
M. R. Kuettel
No relevant relationships to disclose
J. Mohler
No relevant relationships to disclose
K. Guru
No relevant relationships to disclose
D. L. Trump
No relevant relationships to disclose